-
1
-
-
28344454000
-
Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?
-
16145060 10.1200/JCO.2005.03.3845 1:CAS:528:DC%2BD2MXhtF2nsLrJ
-
JD Brenton LA Carey AA Ahmed C Caldas 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 29 7350 7360 16145060 10.1200/JCO.2005.03.3845 1:CAS:528: DC%2BD2MXhtF2nsLrJ
-
(2005)
J Clin Oncol
, vol.23
, Issue.29
, pp. 7350-7360
-
-
Brenton, J.D.1
Carey, L.A.2
Ahmed, A.A.3
Caldas, C.4
-
2
-
-
36048947234
-
Breast cancer: Origins and evolution
-
17975657 10.1172/JCI33295 1:CAS:528:DC%2BD2sXht12ju7fE
-
K Polyak 2007 Breast cancer: origins and evolution J Clin Invest 117 11 3155 3163 17975657 10.1172/JCI33295 1:CAS:528:DC%2BD2sXht12ju7fE
-
(2007)
J Clin Invest
, vol.117
, Issue.11
, pp. 3155-3163
-
-
Polyak, K.1
-
3
-
-
9644310201
-
Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities
-
15571950 10.1016/j.ejca.2004.08.021 1:CAS:528:DC%2BD2cXhtVahurvJ
-
T Sorlie 2004 Molecular portraits of breast cancer: tumour subtypes as distinct disease entities Eur J Cancer 40 18 2667 2675 15571950 10.1016/j.ejca.2004.08.021 1:CAS:528:DC%2BD2cXhtVahurvJ
-
(2004)
Eur J Cancer
, vol.40
, Issue.18
, pp. 2667-2675
-
-
Sorlie, T.1
-
4
-
-
33646874546
-
The molecular portraits of breast tumors are conserved across microarray platforms
-
16643655 10.1186/1471-2164-7-96
-
Z Hu C Fan DS Oh JS Marron X He BF Qaqish C Livasy LA Carey E Reynolds L Dressler A Nobel J Parker MG Ewend LR Sawyer J Wu Y Liu R Nanda M Tretiakova A Ruiz Orrico D Dreher JP Palazzo L Perreard E Nelson M Mone H Hansen M Mullins JF Quackenbush MJ Ellis OI Olopade PS Bernard CM Perou 2006 The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 7 96 16643655 10.1186/1471-2164-7-96
-
(2006)
BMC Genomics
, vol.7
, pp. 96
-
-
Hu, Z.1
Fan, C.2
Oh, D.S.3
Marron, J.S.4
He, X.5
Qaqish, B.F.6
Livasy, C.7
Carey, L.A.8
Reynolds, E.9
Dressler, L.10
Nobel, A.11
Parker, J.12
Ewend, M.G.13
Sawyer, L.R.14
Wu, J.15
Liu, Y.16
Nanda, R.17
Tretiakova, M.18
Ruiz Orrico, A.19
Dreher, D.20
Palazzo, J.P.21
Perreard, L.22
Nelson, E.23
Mone, M.24
Hansen, H.25
Mullins, M.26
Quackenbush, J.F.27
Ellis, M.J.28
Olopade, O.I.29
Bernard, P.S.30
Perou, C.M.31
more..
-
5
-
-
0034680102
-
Molecular portraits of human breast tumours
-
10963602 10.1038/35021093 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
-
CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 6797 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
-
(2000)
Nature
, vol.406
, Issue.6797
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
Van De Rijn, M.4
Jeffrey, S.S.5
Rees, C.A.6
Pollack, J.R.7
Ross, D.T.8
Johnsen, H.9
Akslen, L.A.10
Fluge, O.11
Pergamenschikov, A.12
Williams, C.13
Zhu, S.X.14
Lonning, P.E.15
Borresen-Dale, A.L.16
Brown, P.O.17
Botstein, D.18
-
6
-
-
18244409687
-
Gene expression profiling predicts clinical outcome of breast cancer
-
10.1038/415530a
-
LJ van 't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen GJ Schreiber RM Kerkhoven C Roberts PS Linsley R Bernards SH Friend 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 10.1038/415530a
-
(2002)
Nature
, vol.415
, Issue.6871
, pp. 530-536
-
-
Van 'T Veer, L.J.1
Dai, H.2
Van De Vijver, M.J.3
He, Y.D.4
Hart, A.A.5
Mao, M.6
Peterse, H.L.7
Van Der Kooy, K.8
Marton, M.J.9
Witteveen, A.T.10
Schreiber, G.J.11
Kerkhoven, R.M.12
Roberts, C.13
Linsley, P.S.14
Bernards, R.15
Friend, S.H.16
-
7
-
-
13844310310
-
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
-
15721472 1:CAS:528:DC%2BD2MXhsVOitLk%3D
-
Y Wang JG Klijn Y Zhang AM Sieuwerts MP Look F Yang D Talantov M Timmermans ME Meijer-van Gelder J Yu T Jatkoe EM Berns D Atkins JA Foekens 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 9460 671 679 15721472 1:CAS:528: DC%2BD2MXhsVOitLk%3D
-
(2005)
Lancet
, vol.365
, Issue.9460
, pp. 671-679
-
-
Wang, Y.1
Klijn, J.G.2
Zhang, Y.3
Sieuwerts, A.M.4
Look, M.P.5
Yang, F.6
Talantov, D.7
Timmermans, M.8
Meijer-Van Gelder, M.E.9
Yu, J.10
Jatkoe, T.11
Berns, E.M.12
Atkins, D.13
Foekens, J.A.14
-
8
-
-
48449090298
-
Epigenetic biomarkers for human cancer: The time is now
-
18430583 10.1016/j.critrevonc.2008.03.001
-
S Mulero-Navarro M Esteller 2008 Epigenetic biomarkers for human cancer: the time is now Crit Rev Oncol Hematol 68 1 1 11 18430583 10.1016/j.critrevonc. 2008.03.001
-
(2008)
Crit Rev Oncol Hematol
, vol.68
, Issue.1
, pp. 1-11
-
-
Mulero-Navarro, S.1
Esteller, M.2
-
9
-
-
71749115797
-
Epigenetics and cancer treatment
-
19836388 10.1016/j.ejphar.2009.10.011
-
LS Kristensen HM Nielsen LL Hansen 2009 Epigenetics and cancer treatment Eur J Pharmacol 625 1-3 131 142 19836388 10.1016/j.ejphar.2009.10.011
-
(2009)
Eur J Pharmacol
, vol.625
, Issue.13
, pp. 131-142
-
-
Kristensen, L.S.1
Nielsen, H.M.2
Hansen, L.L.3
-
10
-
-
40849139208
-
Epigenetics in cancer
-
18337604 10.1056/NEJMra072067 1:CAS:528:DC%2BD1cXjt1ahs7Y%3D
-
M Esteller 2008 Epigenetics in cancer N Engl J Med 358 11 1148 1159 18337604 10.1056/NEJMra072067 1:CAS:528:DC%2BD1cXjt1ahs7Y%3D
-
(2008)
N Engl J Med
, vol.358
, Issue.11
, pp. 1148-1159
-
-
Esteller, M.1
-
11
-
-
61549112191
-
Epigenomics and breast cancer
-
19072646 10.2217/14622416.9.12.1879 1:CAS:528:DC%2BD1cXhsFWjtbrE
-
PK Lo S Sukumar 2008 Epigenomics and breast cancer Pharmacogenomics 9 12 1879 1902 19072646 10.2217/14622416.9.12.1879 1:CAS:528:DC%2BD1cXhsFWjtbrE
-
(2008)
Pharmacogenomics
, vol.9
, Issue.12
, pp. 1879-1902
-
-
Lo, P.K.1
Sukumar, S.2
-
12
-
-
34250191386
-
Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles
-
17510312 10.1158/1541-7786.MCR-06-0358
-
MF de Maat N Umetani E Sunami RR Turner DS Hoon 2007 Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles Mol Cancer Res 5 5 461 471 17510312 10.1158/1541-7786.MCR-06-0358
-
(2007)
Mol Cancer Res
, vol.5
, Issue.5
, pp. 461-471
-
-
De Maat, M.F.1
Umetani, N.2
Sunami, E.3
Turner, R.R.4
Hoon, D.S.5
-
13
-
-
36549029229
-
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
-
17764565 10.1186/bcr1762
-
W Feng L Shen S Wen DG Rosen J Jelinek X Hu S Huan M Huang J Liu AA Sahin KK Hunt RC Bast Jr Y Shen JP Issa Y Yu 2007 Correlation between CpG methylation profiles and hormone receptor status in breast cancers Breast Cancer Res 9 4 R57 17764565 10.1186/bcr1762
-
(2007)
Breast Cancer Res
, vol.9
, Issue.4
, pp. 57
-
-
Feng, W.1
Shen, L.2
Wen, S.3
Rosen, D.G.4
Jelinek, J.5
Hu, X.6
Huan, S.7
Huang, M.8
Liu, J.9
Sahin, A.A.10
Hunt, K.K.11
Bast Jr., R.C.12
Shen, Y.13
Issa, J.P.14
Yu, Y.15
-
14
-
-
34648846673
-
Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma
-
17706863 10.1016/j.canlet.2007.07.010 1:CAS:528:DC%2BD2sXhtFSnt7vO
-
L Pasquali A Bedeir S Ringquist A Styche R Bhargava G Trucco 2007 Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma Cancer Lett 257 1 136 144 17706863 10.1016/j.canlet.2007.07.010 1:CAS:528:DC%2BD2sXhtFSnt7vO
-
(2007)
Cancer Lett
, vol.257
, Issue.1
, pp. 136-144
-
-
Pasquali, L.1
Bedeir, A.2
Ringquist, S.3
Styche, A.4
Bhargava, R.5
Trucco, G.6
-
15
-
-
77949463477
-
Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients
-
20226036 10.1186/1471-2407-10-97
-
I Van der Auwera C Bovie C Svensson XB Trinh R Limame P van Dam SJ van Laere EA van Marck LY Dirix PB Vermeulen 2010 Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients BMC Cancer 10 97 20226036 10.1186/1471-2407-10-97
-
(2010)
BMC Cancer
, vol.10
, pp. 97
-
-
Van Der Auwera, I.1
Bovie, C.2
Svensson, C.3
Trinh, X.B.4
Limame, R.5
Van Dam, P.6
Van Laere, S.J.7
Van Marck, E.A.8
Dirix, L.Y.9
Vermeulen, P.B.10
-
16
-
-
0242677806
-
DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma
-
14601057 10.1002/ijc.11508 1:CAS:528:DC%2BD3sXptFOgtLc%3D
-
MJ Fackler M McVeigh E Evron E Garrett J Mehrotra K Polyak S Sukumar P Argani 2003 DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma Int J Cancer 107 6 970 975 14601057 10.1002/ijc.11508 1:CAS:528:DC%2BD3sXptFOgtLc%3D
-
(2003)
Int J Cancer
, vol.107
, Issue.6
, pp. 970-975
-
-
Fackler, M.J.1
McVeigh, M.2
Evron, E.3
Garrett, E.4
Mehrotra, J.5
Polyak, K.6
Sukumar, S.7
Argani, P.8
-
17
-
-
3042825295
-
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer
-
15231653 10.1158/0008-5472.CAN-03-3341 1:CAS:528:DC%2BD2cXltlOrs7Y%3D
-
MJ Fackler M McVeigh J Mehrotra MA Blum J Lange A Lapides E Garrett P Argani S Sukumar 2004 Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer Cancer Res 64 13 4442 4452 15231653 10.1158/0008-5472.CAN-03-3341 1:CAS:528:DC%2BD2cXltlOrs7Y%3D
-
(2004)
Cancer Res
, vol.64
, Issue.13
, pp. 4442-4452
-
-
Fackler, M.J.1
McVeigh, M.2
Mehrotra, J.3
Blum, M.A.4
Lange, J.5
Lapides, A.6
Garrett, E.7
Argani, P.8
Sukumar, S.9
-
18
-
-
16844383767
-
Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis
-
15788661 10.1158/1078-0432.CCR-04-1810 1:CAS:528:DC%2BD2MXisFajtbY%3D
-
M Shinozaki DS Hoon AE Giuliano NM Hansen HJ Wang R Turner B Taback 2005 Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis Clin Cancer Res 11 6 2156 2162 15788661 10.1158/1078-0432.CCR-04-1810 1:CAS:528:DC%2BD2MXisFajtbY%3D
-
(2005)
Clin Cancer Res
, vol.11
, Issue.6
, pp. 2156-2162
-
-
Shinozaki, M.1
Hoon, D.S.2
Giuliano, A.E.3
Hansen, N.M.4
Wang, H.J.5
Turner, R.6
Taback, B.7
-
19
-
-
78149329114
-
Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma
-
20952593 10.2353/ajpath.2010.091103
-
MF de Maat N Narita A Benard T Yoshimura C Kuo RA Tollenaar NF de Miranda RR Turner CJ van de Velde H Morreau DS Hoon 2010 Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma Am J Pathol 177 5 2347 2356 20952593 10.2353/ajpath.2010.091103
-
(2010)
Am J Pathol
, vol.177
, Issue.5
, pp. 2347-2356
-
-
De Maat, M.F.1
Narita, N.2
Benard, A.3
Yoshimura, T.4
Kuo, C.5
Tollenaar, R.A.6
De Miranda, N.F.7
Turner, R.R.8
Van De Velde, C.J.9
Morreau, H.10
Hoon, D.S.11
-
20
-
-
44249087640
-
Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence
-
18467724 10.1200/JCO.2007.14.0723
-
MF de Maat CJ van de Velde MP van der Werff H Putter N Umetani EM Klein-Kranenbarg RR Turner JH van Krieken A Bilchik RA Tollenaar DS Hoon 2008 Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence J Clin Oncol 26 14 2327 2335 18467724 10.1200/JCO.2007.14.0723
-
(2008)
J Clin Oncol
, vol.26
, Issue.14
, pp. 2327-2335
-
-
De Maat, M.F.1
Van De Velde, C.J.2
Van Der Werff, M.P.3
Putter, H.4
Umetani, N.5
Klein-Kranenbarg, E.M.6
Turner, R.R.7
Van Krieken, J.H.8
Bilchik, A.9
Tollenaar, R.A.10
Hoon, D.S.11
-
21
-
-
0033587747
-
CpG island methylator phenotype in colorectal cancer
-
10411935 10.1073/pnas.96.15.8681 1:CAS:528:DyaK1MXkslOktLg%3D
-
M Toyota N Ahuja M Ohe-Toyota JG Herman SB Baylin JP Issa 1999 CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci USA 96 15 8681 8686 10411935 10.1073/pnas.96.15.8681 1:CAS:528:DyaK1MXkslOktLg%3D
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, Issue.15
, pp. 8681-8686
-
-
Toyota, M.1
Ahuja, N.2
Ohe-Toyota, M.3
Herman, J.G.4
Baylin, S.B.5
Issa, J.P.6
-
22
-
-
63449140854
-
CpG island methylator phenotype predicts progression of malignant melanoma
-
19223509 10.1158/1078-0432.CCR-08-1361 1:CAS:528:DC%2BD1MXisVWrsL0%3D
-
A Tanemura AM Terando MS Sim AQ van Hoesel MF de Maat DL Morton DS Hoon 2009 CpG island methylator phenotype predicts progression of malignant melanoma Clin Cancer Res 15 5 1801 1807 19223509 10.1158/1078-0432.CCR-08-1361 1:CAS:528:DC%2BD1MXisVWrsL0%3D
-
(2009)
Clin Cancer Res
, vol.15
, Issue.5
, pp. 1801-1807
-
-
Tanemura, A.1
Terando, A.M.2
Sim, M.S.3
Van Hoesel, A.Q.4
De Maat, M.F.5
Morton, D.L.6
Hoon, D.S.7
-
23
-
-
77957859971
-
Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer
-
20724461 10.1093/hmg/ddq351 1:CAS:528:DC%2BC3cXht1KqurfN
-
L Li KM Lee W Han JY Choi JY Lee GH Kang SK Park DY Noh KY Yoo D Kang 2010 Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer Hum Mol Genet 19 21 4273 4277 20724461 10.1093/hmg/ddq351 1:CAS:528:DC%2BC3cXht1KqurfN
-
(2010)
Hum Mol Genet
, vol.19
, Issue.21
, pp. 4273-4277
-
-
Li, L.1
Lee, K.M.2
Han, W.3
Choi, J.Y.4
Lee, J.Y.5
Kang, G.H.6
Park, S.K.7
Noh, D.Y.8
Yoo, K.Y.9
Kang, D.10
-
24
-
-
55749101607
-
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors
-
18485221 10.1186/bcr2098
-
E Sunami M Shinozaki MS Sim SL Nguyen AT Vu AE Giuliano DS Hoon 2008 Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors Breast Cancer Res 10 3 R46 18485221 10.1186/bcr2098
-
(2008)
Breast Cancer Res
, vol.10
, Issue.3
, pp. 46
-
-
Sunami, E.1
Shinozaki, M.2
Sim, M.S.3
Nguyen, S.L.4
Vu, A.T.5
Giuliano, A.E.6
Hoon, D.S.7
-
25
-
-
79151477240
-
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
-
20358279 10.1007/s10549-010-0854-7
-
JG van Nes EM de Kruijf D Faratian CJ van de Velde H Putter C Falconer VT Smit C Kay MJ van de Vijver PJ Kuppen JM Bartlett 2011 COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients Breast Cancer Res Treat 125 3 671 685 20358279 10.1007/s10549-010-0854-7
-
(2011)
Breast Cancer Res Treat
, vol.125
, Issue.3
, pp. 671-685
-
-
Van Nes, J.G.1
De Kruijf, E.M.2
Faratian, D.3
Van De Velde, C.J.4
Putter, H.5
Falconer, C.6
Smit, V.T.7
Kay, C.8
Van De Vijver, M.J.9
Kuppen, P.J.10
Bartlett, J.M.11
-
26
-
-
33750313576
-
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK
-
16773436 10.1007/s10549-006-9253-5
-
DF Hayes S Ethier ME Lippman 2006 New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK Breast Cancer Res Treat 100 2 237 238 16773436 10.1007/s10549-006-9253-5
-
(2006)
Breast Cancer Res Treat
, vol.100
, Issue.2
, pp. 237-238
-
-
Hayes, D.F.1
Ethier, S.2
Lippman, M.E.3
-
28
-
-
33644830699
-
Reporting recommendations for tumor marker prognostic studies
-
16172462 10.1200/JCO.2004.01.0454
-
LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2005 Reporting recommendations for tumor marker prognostic studies J Clin Oncol 23 36 9067 9072 16172462 10.1200/JCO.2004.01.0454
-
(2005)
J Clin Oncol
, vol.23
, Issue.36
, pp. 9067-9072
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
-
29
-
-
13844266924
-
Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase
-
15721296 10.1016/j.bbrc.2005.01.088 1:CAS:528:DC%2BD2MXhsFSis7w%3D
-
N Umetani MF de Maat T Mori H Takeuchi DS Hoon 2005 Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase Biochem Biophys Res Commun 329 1 219 223 15721296 10.1016/j.bbrc.2005.01.088 1:CAS:528:DC%2BD2MXhsFSis7w%3D
-
(2005)
Biochem Biophys Res Commun
, vol.329
, Issue.1
, pp. 219-223
-
-
Umetani, N.1
De Maat, M.F.2
Mori, T.3
Takeuchi, H.4
Hoon, D.S.5
-
30
-
-
34248397713
-
Tutorial in biostatistics: Competing risks and multi-state models
-
17031868 10.1002/sim.2712 1:STN:280:DC%2BD2s3hs1agsA%3D%3D
-
H Putter M Fiocco RB Geskus 2007 Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 11 2389 2430 17031868 10.1002/sim.2712 1:STN:280:DC%2BD2s3hs1agsA%3D%3D
-
(2007)
Stat Med
, vol.26
, Issue.11
, pp. 2389-2430
-
-
Putter, H.1
Fiocco, M.2
Geskus, R.B.3
-
31
-
-
21044454322
-
Prognostic and predictive markers
-
J. Harris M. Lippman M. Morrow C. Osborne (eds). 4 Lippincott Williams & Wilkins Philadelphia, PA
-
Chang J, Hilsenbeck S (2010) Prognostic and predictive markers. In: Harris J, Lippman M, Morrow M, Osborne C (eds) Diseases of the breast, 4th edn. Lippincott Williams & Wilkins, Philadelphia, PA, pp 443-457
-
(2010)
Diseases of the Breast
, pp. 443-457
-
-
Chang, J.1
Hilsenbeck, S.2
-
32
-
-
36849069347
-
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
-
17954709 10.1200/JCO.2007.14.2364 1:CAS:528:DC%2BD2sXhsVKnsbzK
-
L Harris H Fritsche R Mennel L Norton P Ravdin S Taube MR Somerfield DF Hayes RC Bast Jr 2007 American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 25 33 5287 5312 17954709 10.1200/JCO.2007.14.2364 1:CAS:528:DC%2BD2sXhsVKnsbzK
-
(2007)
J Clin Oncol
, vol.25
, Issue.33
, pp. 5287-5312
-
-
Harris, L.1
Fritsche, H.2
Mennel, R.3
Norton, L.4
Ravdin, P.5
Taube, S.6
Somerfield, M.R.7
Hayes, D.F.8
Bast Jr., R.C.9
-
33
-
-
84856221512
-
Assessment of MINT 17 methylation in primary breast cancer and normal breast epithelia: A preliminary study
-
Abstract 11113
-
van Hoesel AQ, van de Velde CJ, Giuliano AE, Hoon DS (2008) Assessment of MINT 17 methylation in primary breast cancer and normal breast epithelia: a preliminary study. J Clin Oncol: Abstract 11113
-
(2008)
J Clin Oncol
-
-
Van Hoesel, A.Q.1
Van De Velde, C.J.2
Giuliano, A.E.3
Hoon, D.S.4
-
34
-
-
34248214791
-
Hormone receptor status, tumor characteristics, and prognosis: A prospective cohort of breast cancer patients
-
17239243 10.1186/bcr1639
-
LK Dunnwald MA Rossing CI Li 2007 Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients Breast Cancer Res 9 1 R6 17239243 10.1186/bcr1639
-
(2007)
Breast Cancer Res
, vol.9
, Issue.1
, pp. 6
-
-
Dunnwald, L.K.1
Rossing, M.A.2
Li, C.I.3
-
35
-
-
78249249431
-
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
-
20127405 10.1007/s10549-010-0761-y 1:CAS:528:DC%2BC3cXhtlyrsrvF
-
I Castellano E Allia V Accortanzo AM Vandone L Chiusa R Arisio A Durando M Donadio G Bussolati AS Coates G Viale A Sapino 2010 Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers Breast Cancer Res Treat 124 3 607 617 20127405 10.1007/s10549-010-0761-y 1:CAS:528:DC%2BC3cXhtlyrsrvF
-
(2010)
Breast Cancer Res Treat
, vol.124
, Issue.3
, pp. 607-617
-
-
Castellano, I.1
Allia, E.2
Accortanzo, V.3
Vandone, A.M.4
Chiusa, L.5
Arisio, R.6
Durando, A.7
Donadio, M.8
Bussolati, G.9
Coates, A.S.10
Viale, G.11
Sapino, A.12
-
36
-
-
73249140371
-
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: A retrospective analysis of a randomised trial
-
20005174 10.1016/S1470-2045(09)70314-6 1:CAS:528:DC%2BC3cXjslKrtQ%3D%3D
-
KS Albain WE Barlow S Shak GN Hortobagyi RB Livingston IT Yeh P Ravdin R Bugarini FL Baehner NE Davidson GW Sledge EP Winer C Hudis JN Ingle EA Perez KI Pritchard L Shepherd JR Gralow C Yoshizawa DC Allred CK Osborne DF Hayes 2010 Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Lancet Oncol 11 1 55 65 20005174 10.1016/S1470-2045(09)70314-6 1:CAS:528: DC%2BC3cXjslKrtQ%3D%3D
-
(2010)
Lancet Oncol
, vol.11
, Issue.1
, pp. 55-65
-
-
Albain, K.S.1
Barlow, W.E.2
Shak, S.3
Hortobagyi, G.N.4
Livingston, R.B.5
Yeh, I.T.6
Ravdin, P.7
Bugarini, R.8
Baehner, F.L.9
Davidson, N.E.10
Sledge, G.W.11
Winer, E.P.12
Hudis, C.13
Ingle, J.N.14
Perez, E.A.15
Pritchard, K.I.16
Shepherd, L.17
Gralow, J.R.18
Yoshizawa, C.19
Allred, D.C.20
Osborne, C.K.21
Hayes, D.F.22
more..
-
37
-
-
44949121510
-
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
-
18498629 10.1186/1471-2164-9-239
-
S Loi B Haibe-Kains C Desmedt P Wirapati F Lallemand AM Tutt C Gillet P Ellis K Ryder JF Reid MG Daidone MA Pierotti EM Berns MP Jansen JA Foekens M Delorenzi G Bontempi MJ Piccart C Sotiriou 2008 Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen BMC Genomics 9 239 18498629 10.1186/1471-2164-9-239
-
(2008)
BMC Genomics
, vol.9
, pp. 239
-
-
Loi, S.1
Haibe-Kains, B.2
Desmedt, C.3
Wirapati, P.4
Lallemand, F.5
Tutt, A.M.6
Gillet, C.7
Ellis, P.8
Ryder, K.9
Reid, J.F.10
Daidone, M.G.11
Pierotti, M.A.12
Berns, E.M.13
Jansen, M.P.14
Foekens, J.A.15
Delorenzi, M.16
Bontempi, G.17
Piccart, M.J.18
Sotiriou, C.19
-
38
-
-
77950482645
-
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: Results from NSABP B-14 and NSABP B-20
-
20065188 10.1200/JCO.2009.23.7610
-
EP Mamounas G Tang B Fisher S Paik S Shak JP Costantino D Watson CE Geyer Jr DL Wickerham N Wolmark 2010 Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 J Clin Oncol 28 10 1677 1683 20065188 10.1200/JCO.2009.23.7610
-
(2010)
J Clin Oncol
, vol.28
, Issue.10
, pp. 1677-1683
-
-
Mamounas, E.P.1
Tang, G.2
Fisher, B.3
Paik, S.4
Shak, S.5
Costantino, J.P.6
Watson, D.7
Geyer Jr., C.E.8
Wickerham, D.L.9
Wolmark, N.10
-
39
-
-
54549097590
-
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
-
18631401 10.1186/bcr2120
-
C Yau CC Benz 2008 Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers Breast Cancer Res 10 4 R61 18631401 10.1186/bcr2120
-
(2008)
Breast Cancer Res
, vol.10
, Issue.4
, pp. 61
-
-
Yau, C.1
Benz, C.C.2
-
40
-
-
74049137968
-
Expression of FOXA1 and GATA-3 in breast cancer: The prognostic significance in hormone receptor-negative tumours
-
19549328 10.1186/bcr2327
-
A Albergaria J Paredes B Sousa F Milanezi V Carneiro J Bastos S Costa D Vieira N Lopes EW Lam N Lunet F Schmitt 2009 Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours Breast Cancer Res 11 3 R40 19549328 10.1186/bcr2327
-
(2009)
Breast Cancer Res
, vol.11
, Issue.3
, pp. 40
-
-
Albergaria, A.1
Paredes, J.2
Sousa, B.3
Milanezi, F.4
Carneiro, V.5
Bastos, J.6
Costa, S.7
Vieira, D.8
Lopes, N.9
Lam, E.W.10
Lunet, N.11
Schmitt, F.12
-
41
-
-
77952821751
-
FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer
-
20406990 10.1158/0008-5472.CAN-09-4120 1:CAS:528:DC%2BC3cXlvFyrtL8%3D
-
PS Ray J Wang Y Qu MS Sim J Shamonki SP Bagaria X Ye B Liu D Elashoff DS Hoon MA Walter JW Martens AL Richardson AE Giuliano X Cui 2010 FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer Cancer Res 70 10 3870 3876 20406990 10.1158/0008-5472.CAN-09-4120 1:CAS:528:DC%2BC3cXlvFyrtL8%3D
-
(2010)
Cancer Res
, vol.70
, Issue.10
, pp. 3870-3876
-
-
Ray, P.S.1
Wang, J.2
Qu, Y.3
Sim, M.S.4
Shamonki, J.5
Bagaria, S.P.6
Ye, X.7
Liu, B.8
Elashoff, D.9
Hoon, D.S.10
Walter, M.A.11
Martens, J.W.12
Richardson, A.L.13
Giuliano, A.E.14
Cui, X.15
-
42
-
-
70350235064
-
Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer
-
19808870 10.1158/1078-0432.CCR-09-1107 1:CAS:528:DC%2BD1MXhtlyqsLfK
-
C Speers A Tsimelzon K Sexton AM Herrick C Gutierrez A Culhane J Quackenbush S Hilsenbeck J Chang P Brown 2009 Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer Clin Cancer Res 15 20 6327 6340 19808870 10.1158/1078-0432.CCR-09-1107 1:CAS:528:DC%2BD1MXhtlyqsLfK
-
(2009)
Clin Cancer Res
, vol.15
, Issue.20
, pp. 6327-6340
-
-
Speers, C.1
Tsimelzon, A.2
Sexton, K.3
Herrick, A.M.4
Gutierrez, C.5
Culhane, A.6
Quackenbush, J.7
Hilsenbeck, S.8
Chang, J.9
Brown, P.10
-
43
-
-
34648829133
-
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
-
17683518 10.1186/gb-2007-8-8-r157
-
AE Teschendorff A Miremadi SE Pinder IO Ellis C Caldas 2007 An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer Genome Biol 8 8 R157 17683518 10.1186/gb-2007-8-8-r157
-
(2007)
Genome Biol
, vol.8
, Issue.8
, pp. 157
-
-
Teschendorff, A.E.1
Miremadi, A.2
Pinder, S.E.3
Ellis, I.O.4
Caldas, C.5
-
44
-
-
33645729203
-
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
-
16609087 10.1001/jama.295.14.1658 1:CAS:528:DC%2BD28XjsVeqs7k%3D
-
DA Berry C Cirrincione IC Henderson ML Citron DR Budman LJ Goldstein S Martino EA Perez HB Muss L Norton C Hudis EP Winer 2006 Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer JAMA 295 14 1658 1667 16609087 10.1001/jama.295.14.1658 1:CAS:528:DC%2BD28XjsVeqs7k%3D
-
(2006)
JAMA
, vol.295
, Issue.14
, pp. 1658-1667
-
-
Berry, D.A.1
Cirrincione, C.2
Henderson, I.C.3
Citron, M.L.4
Budman, D.R.5
Goldstein, L.J.6
Martino, S.7
Perez, E.A.8
Muss, H.B.9
Norton, L.10
Hudis, C.11
Winer, E.P.12
-
45
-
-
77954576948
-
Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
-
20458051 10.1200/JCO.2009.25.9549 1:CAS:528:DC%2BC3cXptlajtbY%3D
-
M Colleoni BF Cole G Viale MM Regan KN Price E Maiorano MG Mastropasqua D Crivellari RD Gelber A Goldhirsch AS Coates BA Gusterson 2010 Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer J Clin Oncol 28 18 2966 2973 20458051 10.1200/JCO.2009.25.9549 1:CAS:528: DC%2BC3cXptlajtbY%3D
-
(2010)
J Clin Oncol
, vol.28
, Issue.18
, pp. 2966-2973
-
-
Colleoni, M.1
Cole, B.F.2
Viale, G.3
Regan, M.M.4
Price, K.N.5
Maiorano, E.6
Mastropasqua, M.G.7
Crivellari, D.8
Gelber, R.D.9
Goldhirsch, A.10
Coates, A.S.11
Gusterson, B.A.12
-
46
-
-
77950409567
-
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing
-
20181289 10.1186/1471-2164-11-137
-
Y Ruike Y Imanaka F Sato K Shimizu G Tsujimoto 2010 Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing BMC Genomics 11 137 20181289 10.1186/1471-2164-11-137
-
(2010)
BMC Genomics
, vol.11
, pp. 137
-
-
Ruike, Y.1
Imanaka, Y.2
Sato, F.3
Shimizu, K.4
Tsujimoto, G.5
-
47
-
-
52949122883
-
Cell type-specific DNA methylation patterns in the human breast
-
18780791 10.1073/pnas.0805206105 1:CAS:528:DC%2BD1cXhtFKiurjN
-
N Bloushtain-Qimron J Yao EL Snyder M Shipitsin LL Campbell SA Mani M Hu H Chen V Ustyansky JE Antosiewicz P Argani MK Halushka JA Thomson P Pharoah A Porgador S Sukumar R Parsons AL Richardson MR Stampfer RS Gelman T Nikolskaya Y Nikolsky K Polyak 2008 Cell type-specific DNA methylation patterns in the human breast Proc Natl Acad Sci USA 105 37 14076 14081 18780791 10.1073/pnas. 0805206105 1:CAS:528:DC%2BD1cXhtFKiurjN
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.37
, pp. 14076-14081
-
-
Bloushtain-Qimron, N.1
Yao, J.2
Snyder, E.L.3
Shipitsin, M.4
Campbell, L.L.5
Mani, S.A.6
Hu, M.7
Chen, H.8
Ustyansky, V.9
Antosiewicz, J.E.10
Argani, P.11
Halushka, M.K.12
Thomson, J.A.13
Pharoah, P.14
Porgador, A.15
Sukumar, S.16
Parsons, R.17
Richardson, A.L.18
Stampfer, M.R.19
Gelman, R.S.20
Nikolskaya, T.21
Nikolsky, Y.22
Polyak, K.23
more..
-
48
-
-
58849143465
-
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy
-
19118060 10.1158/1078-0432.CCR-08-0166 1:CAS:528:DC%2BD1MXhs1eqsg%3D%3D
-
O Hartmann F Spyratos N Harbeck D Dietrich A Fassbender M Schmitt S Eppenberger-Castori V Vuaroqueaux F Lerebours K Welzel S Maier A Plum S Niemann JA Foekens R Lesche JW Martens 2009 DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy Clin Cancer Res 15 1 315 323 19118060 10.1158/1078-0432.CCR-08-0166 1:CAS:528:DC%2BD1MXhs1eqsg%3D%3D
-
(2009)
Clin Cancer Res
, vol.15
, Issue.1
, pp. 315-323
-
-
Hartmann, O.1
Spyratos, F.2
Harbeck, N.3
Dietrich, D.4
Fassbender, A.5
Schmitt, M.6
Eppenberger-Castori, S.7
Vuaroqueaux, V.8
Lerebours, F.9
Welzel, K.10
Maier, S.11
Plum, A.12
Niemann, S.13
Foekens, J.A.14
Lesche, R.15
Martens, J.W.16
-
49
-
-
34447262607
-
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients-Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group
-
17601725 10.1016/j.ejca.2007.04.025 1:CAS:528:DC%2BD2sXnslWjtLs%3D
-
S Maier I Nimmrich T Koenig S Eppenberger-Castori I Bohlmann A Paradiso F Spyratos C Thomssen V Mueller J Nahrig F Schittulli R Kates R Lesche I Schwope A Kluth A Marx JW Martens JA Foekens M Schmitt N Harbeck 2007 DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients-Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group Eur J Cancer 43 11 1679 1686 17601725 10.1016/j.ejca.2007.04.025 1:CAS:528:DC%2BD2sXnslWjtLs%3D
-
(2007)
Eur J Cancer
, vol.43
, Issue.11
, pp. 1679-1686
-
-
Maier, S.1
Nimmrich, I.2
Koenig, T.3
Eppenberger-Castori, S.4
Bohlmann, I.5
Paradiso, A.6
Spyratos, F.7
Thomssen, C.8
Mueller, V.9
Nahrig, J.10
Schittulli, F.11
Kates, R.12
Lesche, R.13
Schwope, I.14
Kluth, A.15
Marx, A.16
Martens, J.W.17
Foekens, J.A.18
Schmitt, M.19
Harbeck, N.20
more..
|